Tensions between science and policy reached a flashpoint at one of the largest diabetes gatherings last week, where five leading researchers were forcibly removed from the American Diabetes Association’s annual conference in New Orleans. The scientists had distributed reprints of a recently published editorial in Diabetes Care, a peer-reviewed journal, that challenged the Trump administration’s ongoing efforts to undermine independent research funding and scientific integrity.
The editorial, titled Misguided Brushes of a Pen Continue to Dismantle, was released on April 29. It argued that repeated political interference in scientific processes threatens both public health and the credibility of medical research. Among the co-authors were Steven Kahn, editor-in-chief of Diabetes Care and a professor of medicine at the University of Washington; Desmond Schatz, former ADA president and a University of Florida researcher; and Aaron Kelly, a pediatric specialist at the University of Minnesota. Also removed were Justin Ryder from Northwestern University and Irl Hirsch, also from the University of Washington.
How the confrontation unfolded
The incident occurred outside a scheduled presentation featuring Jay Bhattacharya, director of the National Institutes of Health (NIH). Bhattacharya canceled his appearance, and a substitute NIH official delivered remarks instead. According to Kelly’s interview with MedPage Today, conference staff confronted the researchers as they handed out the reprints. He described the removal as abrupt and forceful: “They physically grabbed us, forced us out of the conference center, and now are telling us we can no longer attend this meeting. They're taking our lanyards. It really has come to this in America. Censorship is real.”
Kelly emphasized the symbolic weight of the action: “America needs to stand up. Scientists, stand up. Physicians, stand up.” His statement reflects growing concern within the scientific community that attempts to silence critical voices are accelerating, particularly when research conflicts with political narratives.
Why the editorial sparked controversy
The published critique in Diabetes Care was not a casual opinion piece. It cited multiple documented instances of federal agencies altering or suppressing scientific reports, reallocating grant funding based on ideological alignment, and dismissing expert panels without adequate justification. The authors argued that such actions erode public trust in medical institutions and jeopardize patient care, especially in chronic conditions like diabetes, where evidence-based treatment remains essential.
Conference organizers did not publicly respond to the incident, though the ADA has historically emphasized inclusivity and open dialogue. The forced removal of credentialed researchers—many of whom hold leadership roles in diabetes care—raises questions about the organization’s commitment to academic freedom and its ability to host balanced, evidence-driven discussions.
What comes next?
While the immediate fallout focuses on the ADA’s response, the broader implications are more concerning. Researchers across disciplines are increasingly documenting attempts to politicize science, from climate research to drug development. The removal of five experts for distributing a peer-reviewed critique signals a dangerous precedent: that questioning authority may now carry professional consequences at major medical events.
As the diabetes community reflects on the incident, the focus shifts to whether scientific institutions will prioritize integrity over compliance. The next ADA conference is months away, but the conversation about censorship and autonomy has already begun—and it won’t end quietly.
AI summary
Amerikan Diyabet Derneği konferansında sansür iddiası patlak verdi. Beş araştırmacı, eleştirel bir dergi makalesi dağıttıkları gerekçesiyle zorla dışarı çıkarıldı. Olayın detayları ve bilim dünyasındaki yansımaları.
